315 related articles for article (PubMed ID: 30159809)
1. Platelet-Derived Microparticles: A New Index of Monitoring Platelet Activation and Inflammation in Kawasaki Disease.
Jin J; Wang J; Lu Y; Fan Z; Huang N; Ma L; Yu H
Indian J Pediatr; 2019 Mar; 86(3):250-255. PubMed ID: 30159809
[TBL] [Abstract][Full Text] [Related]
2. The Usefulness of Platelet-derived Microparticle as Biomarker of Antiplatelet Therapy in Kawasaki Disease.
Kim HJ; Choi EH; Lim YJ; Kil HR
J Korean Med Sci; 2017 Jul; 32(7):1147-1153. PubMed ID: 28581272
[TBL] [Abstract][Full Text] [Related]
3. Platelet activation dynamics evaluated using platelet-derived microparticles in Kawasaki disease.
Yahata T; Suzuki C; Yoshioka A; Hamaoka A; Ikeda K
Circ J; 2014; 78(1):188-93. PubMed ID: 24152721
[TBL] [Abstract][Full Text] [Related]
4. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
Peng Q; Wu Q; Chen CH; Hong H; Zhang LY
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593
[TBL] [Abstract][Full Text] [Related]
5. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
Ye Q; Shao WX; Shang SQ; Zhang T; Hu J; Zhang CC
Arthritis Rheumatol; 2015 Jul; 67(7):1943-50. PubMed ID: 25778686
[TBL] [Abstract][Full Text] [Related]
6. TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.
Hu P; Jiang GM; Wu Y; Huang BY; Liu SY; Zhang DD; Xu Y; Wu YF; Xia X; Wei W; Hu B
Clin Chim Acta; 2017 Aug; 471():76-80. PubMed ID: 28526535
[TBL] [Abstract][Full Text] [Related]
7. Do cytokines correlate with refractory Kawasaki disease in children?
Wang Y; Qian SY; Yuan Y; Wang Q; Gao L; Chen X; Yu X; Zhen Z
Clin Chim Acta; 2020 Jul; 506():222-227. PubMed ID: 32156603
[TBL] [Abstract][Full Text] [Related]
8. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH
PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843
[TBL] [Abstract][Full Text] [Related]
9. [Expression of interleukin-17A in serum of children with intravenous immunoglobulin-resistant Kawasaki disease and its clinical significance].
Li SY; Ding Y
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Mar; 25(3):244-249. PubMed ID: 36946157
[TBL] [Abstract][Full Text] [Related]
10. The effects of glucocorticoid plus intravenous immunoglobulin (IVIG) vs IVIG alone on platelet activation in children with Kawasaki disease.
Wang QQ; Zheng LY; Zhao S
Turk J Pediatr; 2023; 65(4):640-649. PubMed ID: 37661679
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
Qin LJ; Wang HW; Hu XF; Liu QJ; Shi H; Wei YX; Chen QJ; Cheng PX
Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):891-5. PubMed ID: 17254453
[TBL] [Abstract][Full Text] [Related]
12. Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment.
Gupta M; Noel GJ; Schaefer M; Friedman D; Bussel J; Johann-Liang R
J Clin Immunol; 2001 May; 21(3):193-9. PubMed ID: 11403226
[TBL] [Abstract][Full Text] [Related]
13. [Serum levels of interleukin-38 and interleukin-1β in the acute phase of Kawasaki disease in children].
Zhang XY; He T; Ling JY; Hu XF; Wen Y; Wei J; Lu HL
Zhongguo Dang Dai Er Ke Za Zhi; 2018 Jul; 20(7):543-548. PubMed ID: 30022755
[TBL] [Abstract][Full Text] [Related]
14. Value of C-reactive protein/albumin ratio in predicting intravenous immunoglobulin-resistant Kawasaki disease- a data from multi-institutional study in China.
Li G; Wang T; Gou Y; Zeng R; Liu D; Duan Y; Liu B
Int Immunopharmacol; 2020 Dec; 89(Pt A):107037. PubMed ID: 33242833
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
Sato S; Kawashima H; Kashiwagi Y; Hoshika A
Int J Rheum Dis; 2013 Apr; 16(2):168-72. PubMed ID: 23773640
[TBL] [Abstract][Full Text] [Related]
16. Intravenous Immunoglobulin Gamma (IVIG) versus IVIG Plus Infliximab in Young Children with Kawasaki Disease.
Han CL; Zhao SL
Med Sci Monit; 2018 Oct; 24():7264-7270. PubMed ID: 30307902
[TBL] [Abstract][Full Text] [Related]
17. [A retrospective analysis of 602 Kawasaki disease cases with electronic data capture system].
Xie L; Zhou C; Wang R; Xiao T; Shen J; Huang M
Zhonghua Er Ke Za Zhi; 2015 Jan; 53(1):34-9. PubMed ID: 25748402
[TBL] [Abstract][Full Text] [Related]
18. Circulating platelet-neutrophil aggregates play a significant role in Kawasaki disease.
Ueno K; Nomura Y; Morita Y; Eguchi T; Masuda K; Kawano Y
Circ J; 2015; 79(6):1349-56. PubMed ID: 25787672
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of C1q/tumor necrosis factor-related protein-1 in children with Kawasaki disease.
Feng S; Su Y; Luo L; Jing F; Yi Q
Pediatr Res; 2018 May; 83(5):999-1003. PubMed ID: 29360808
[TBL] [Abstract][Full Text] [Related]
20. Retrospective study of the course, treatment and long-term follow-up of Kawasaki disease: a single-center experience from Poland.
Stasiak A; Smolewska E
Rheumatol Int; 2019 Jun; 39(6):1069-1076. PubMed ID: 30903369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
